Correlation Between Bionoid Pharma and Now Corp
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Now Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Now Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Now Corp, you can compare the effects of market volatilities on Bionoid Pharma and Now Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Now Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Now Corp.
Diversification Opportunities for Bionoid Pharma and Now Corp
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Bionoid and Now is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Now Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Now Corp and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Now Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Now Corp has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Now Corp go up and down completely randomly.
Pair Corralation between Bionoid Pharma and Now Corp
Given the investment horizon of 90 days Bionoid Pharma is expected to generate 52.86 times less return on investment than Now Corp. But when comparing it to its historical volatility, Bionoid Pharma is 14.21 times less risky than Now Corp. It trades about 0.08 of its potential returns per unit of risk. Now Corp is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 0.02 in Now Corp on August 26, 2024 and sell it today you would lose (0.01) from holding Now Corp or give up 50.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Bionoid Pharma vs. Now Corp
Performance |
Timeline |
Bionoid Pharma |
Now Corp |
Bionoid Pharma and Now Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bionoid Pharma and Now Corp
The main advantage of trading using opposite Bionoid Pharma and Now Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Now Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Now Corp will offset losses from the drop in Now Corp's long position.Bionoid Pharma vs. Green Cures Botanical | Bionoid Pharma vs. Indoor Harvest Corp | Bionoid Pharma vs. Speakeasy Cannabis Club | Bionoid Pharma vs. Benchmark Botanics |
Now Corp vs. Green Cures Botanical | Now Corp vs. Indoor Harvest Corp | Now Corp vs. Speakeasy Cannabis Club | Now Corp vs. Benchmark Botanics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |